首页> 外文期刊>ACS medicinal chemistry letters >Structural Insights into Interaction Mechanisms of Alternative Piperazine-urea YEATS Domain Binders in MLLT1
【24h】

Structural Insights into Interaction Mechanisms of Alternative Piperazine-urea YEATS Domain Binders in MLLT1

机译:替代哌嗪 - 尿素的相互作用机制的结构见解,MLT1中的含量域粘合剂域粘合剂

获取原文
获取原文并翻译 | 示例
       

摘要

YEATS-domain-containing MLLT1 is an acetyl/aryl-lysine reader domain, which is structurally distinct from well-studied bromodomains and has been strongly associated in development of cancer. Here, we characterized piperazine-urea derivatives as an acetyl/acyl-lysine mimetic moiety for MLLT1. Crystal structures revealed distinct interaction mechanisms of this chemotype compared to the recently described benzimidazole-amide based inhibitors, exploiting different binding pockets within the protein. Thus, the piperazine-urea scaffold offers an alternative strategy for targeting the YEATS domain family.
机译:含有含有型域的MLT1是乙酰/芳基赖氨酸读卡器结构域,其在结构上不同于研究的溴染色瘤并且在癌症的发展中具有强烈关联。 在此,我们将哌嗪 - 尿素衍生物作为Mμt1的乙酰基/酰基赖氨酸模拟物部分。 与最近描述的苯并咪唑 - 酰胺基抑制剂相比,晶体结构揭示了该趋化型的不同的相互作用机制,利用蛋白质中的不同结合袋。 因此,哌嗪 - 尿素脚手架提供替代策略,用于瞄准叶片域系列。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号